U.S. Department of Health & Human Services Divider Arrow National Institutes of Health Divider Arrow NCATS

Details

Stereochemistry ACHIRAL
Molecular Formula C30H24O9
Molecular Weight 528.5062
Optical Activity NONE
Defined Stereocenters 0 / 0
E/Z Centers 0
Charge 0

SHOW SMILES / InChI
Structure of HYPOCRELLIN B

SMILES

COC1=CC(O)=C2C3=C4C(=C(C)CC5=C(OC)C(=O)C(O)=C6C=C(OC)C1=C2C6=C45)C(C(C)=O)=C(OC)C3=O

InChI

InChIKey=KPGRZWCQXQUGHK-UHFFFAOYSA-N
InChI=1S/C30H24O9/c1-10-7-13-20-19-12(26(33)28(35)29(13)38-5)8-15(36-3)22-16(37-4)9-14(32)21(24(19)22)25-23(20)17(10)18(11(2)31)30(39-6)27(25)34/h8-9,32H,7H2,1-6H3,(H,33,35)

HIDE SMILES / InChI

Molecular Formula C30H24O9
Molecular Weight 528.5062
Charge 0
Count
Stereochemistry ACHIRAL
Additional Stereochemistry No
Defined Stereocenters 0 / 0
E/Z Centers 0
Optical Activity NONE

Hypocrellin B (HB), a natural perylenequinone pigment, has been successfully employed in the photodynamic therapy (PDT) in a variety of human cancer cells due to its high singlet oxygen yield. Hypocrellin B exhibits antibacterial, anti-metastatic, and anticancer chemotherapeutic activities. Hypocrellin B inhibits proliferation of Staphylococcus by increasing ROS levels and damaging cell walls. In ovarian cancer cells, this compound induces apoptosis and inhibits cell migration and adhesion under photodynamic stimulation; it also induces tumor regression in animal models of lymphoma. In vitro, hypocrellin B induces DNA strand breakage.

Approval Year

PubMed

PubMed

TitleDatePubMed
Cytoprotective role of nitric oxide in HepG2 cell apoptosis induced by hypocrellin B photodynamic treatment.
2016-10
Effect of photodynamic therapy with hypocrellin B on apoptosis, adhesion, and migration of cancer cells.
2014-07
Inactivation of Staphylococcus aureus by photodynamic action of hypocrellin B.
2013-12
Patents

Sample Use Guides

The mice were randomly divided into 4 groups (n = 5 each) and injected twice (on days 0 and 7) with PBS, free Hypocrellin B (HB), HB-NPs, or HB-P-NPs via the tail vein (2 mg/kg as HB). 24 h after injection, tumor sites were irradiated with a PDT laser (630 nm, 400 mW/cm2) for 500 sec (200 J/cm2) twice (on days 1 and 8).
Route of Administration: Intravenous
Human ovarian cancer HO-8910 cell as a cancer model cell was incubated with hypocrellin B at a concentration of 2.5 uM for 5 h and irradiated by light from a light-emitting diodes (LED) source. Flow cytometry with annexin V/PI staining showed that early apoptotic and late apoptotic (necrotic) rates following photodynamic therapy with hypocrellin B markedly increased to 16.40% and 24.67%, respectively.
Substance Class Chemical
Created
by admin
on Mon Mar 31 19:02:02 GMT 2025
Edited
by admin
on Mon Mar 31 19:02:02 GMT 2025
Record UNII
XNP7UO129A
Record Status Validated (UNII)
Record Version
  • Download
Name Type Language
HYPOCRELLIN B
Common Name English
1H-CYCLOHEPTA(GHI)PERYLENE-5,12-DIONE, 3-ACETYL-6,11-DIHYDROXY-4,8,9,13-TETRAMETHOXY-2-METHYL-
Preferred Name English
Code System Code Type Description
EPA CompTox
DTXSID30924644
Created by admin on Mon Mar 31 19:02:02 GMT 2025 , Edited by admin on Mon Mar 31 19:02:02 GMT 2025
PRIMARY
CAS
123940-54-5
Created by admin on Mon Mar 31 19:02:02 GMT 2025 , Edited by admin on Mon Mar 31 19:02:02 GMT 2025
PRIMARY
FDA UNII
XNP7UO129A
Created by admin on Mon Mar 31 19:02:02 GMT 2025 , Edited by admin on Mon Mar 31 19:02:02 GMT 2025
PRIMARY